MARTHA TSABETSAYE: Open Payments
NPI 1700151545 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 53 payments from 11 companies in 2025. Trend: 2023 $434 · 2024 $1,602 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 18 | $521 |
| Gilead Sciences, Inc. | 13 | $416 |
| Novo Nordisk Inc | 7 | $214 |
| Amgen Inc. | 3 | $148 |
| Abbott Laboratories | 3 | $58 |
| Exact Sciences Corporation | 3 | $56 |
| EMD Serono, Inc. | 2 | $32 |
| Genentech USA, Inc. | 1 | $31 |
| UCB, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $22 |
Products named: Wegovy, CABENUVA, DOVATO, EVENITY, Yeztugo, APRETUDE, FREESTYLE LIBRE 3, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
